Mendelian randomization for studying the effects of perturbing drug targets.
Gill D, Georgakis MK, Walker VM, Schmidt AF, Gkatzionis A, Freitag DF, Finan C, Hingorani AD, Howson JMM, Burgess S, Swerdlow DI, Davey Smith G, Holmes MV, Dichgans M, Scott RA, Zheng J, Psaty BM, Davies NM.
Gill D, et al. Among authors: freitag df.
Wellcome Open Res. 2021 Feb 10;6:16. doi: 10.12688/wellcomeopenres.16544.2. eCollection 2021.
Wellcome Open Res. 2021.
PMID: 33644404
Free PMC article.
Review.